Michael Tracy1, Jonathan Cogen, Lucas R Hoffman. 1. aDepartment of Pediatrics, Stanford University, Stanford, California bDepartment of Pediatrics, University of Washington cSeattle Children's Hospital dDepartment of Microbiology, University of Washington, Seattle, Washington, USA *Michael Tracy and Jonathan Cogen contributed equally to the writing of this article.
Abstract
PURPOSE OF REVIEW: Many pediatric lung diseases are characterized by infection. These infections are generally diagnosed, studied, and treated using standard culture methods to identify 'traditional pathogens'. Based on these techniques, healthy lungs have generally been thought to be sterile. However, recent advances in culture-independent microbiological techniques challenged this paradigm by identifying diverse microbes in respiratory specimens (respiratory microbiomes) from both healthy people and those with diverse lung diseases. In addition, growing evidence suggests a link between gastrointestinal microbiomes and inflammatory diseases of various mucosal surfaces, including airways. RECENT FINDINGS: This article reviews the rapidly developing field of respiratory microbiome research, emphasizing recent progress made employing increasingly sophisticated technologies. Although many of the relevant studies have focused on adults with cystic fibrosis, recent research has included children and adults with other respiratory diseases, as well as healthy individuals. These studies suggest that even healthy children have airway microbiomes, and that both respiratory and gastrointestinal microbiomes often differ between healthy people and those with different types and severities of airway disease. The causal relationships between microbiomes, disease type and progression, and treatments such as antibiotics must now be defined. SUMMARY: The advent of culture-independent microbiological techniques has transformed how we think about the relationship between microbes and airway disease. More research is required to translate these findings to improved therapies and preventive strategies.
PURPOSE OF REVIEW: Many pediatric lung diseases are characterized by infection. These infections are generally diagnosed, studied, and treated using standard culture methods to identify 'traditional pathogens'. Based on these techniques, healthy lungs have generally been thought to be sterile. However, recent advances in culture-independent microbiological techniques challenged this paradigm by identifying diverse microbes in respiratory specimens (respiratory microbiomes) from both healthy people and those with diverse lung diseases. In addition, growing evidence suggests a link between gastrointestinal microbiomes and inflammatory diseases of various mucosal surfaces, including airways. RECENT FINDINGS: This article reviews the rapidly developing field of respiratory microbiome research, emphasizing recent progress made employing increasingly sophisticated technologies. Although many of the relevant studies have focused on adults with cystic fibrosis, recent research has included children and adults with other respiratory diseases, as well as healthy individuals. These studies suggest that even healthy children have airway microbiomes, and that both respiratory and gastrointestinal microbiomes often differ between healthy people and those with different types and severities of airway disease. The causal relationships between microbiomes, disease type and progression, and treatments such as antibiotics must now be defined. SUMMARY: The advent of culture-independent microbiological techniques has transformed how we think about the relationship between microbes and airway disease. More research is required to translate these findings to improved therapies and preventive strategies.
Authors: F Armougom; F Bittar; N Stremler; J-M Rolain; C Robert; J-C Dubus; J Sarles; D Raoult; B La Scola Journal: Eur J Clin Microbiol Infect Dis Date: 2009-05-16 Impact factor: 3.267
Authors: Franziska A Stressmann; Geraint B Rogers; Peter Marsh; Andrew K Lilley; Thomas W V Daniels; Mary P Carroll; Lucas R Hoffman; Graeme Jones; Collette E Allen; Nilesh Patel; Benjamin Forbes; Andrew Tuck; Kenneth D Bruce Journal: J Cyst Fibros Date: 2011-06-12 Impact factor: 5.482
Authors: Amanda F Goddard; Benjamin J Staudinger; Scot E Dowd; Amruta Joshi-Datar; Randall D Wolcott; Moira L Aitken; Corinne L Fligner; Pradeep K Singh Journal: Proc Natl Acad Sci U S A Date: 2012-08-07 Impact factor: 11.205
Authors: Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight Journal: Proc Natl Acad Sci U S A Date: 2010-06-21 Impact factor: 11.205
Authors: Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch Journal: PLoS One Date: 2010-06-23 Impact factor: 3.240
Authors: Perry S Brown; Christopher E Pope; Robyn L Marsh; Xuan Qin; Sharon McNamara; Ronald Gibson; Jane L Burns; Gail Deutsch; Lucas R Hoffman Journal: Ann Am Thorac Soc Date: 2014-09
Authors: Christoph Arneitz; Jana Windhaber; Christoph Castellani; Bernhard Kienesberger; Ingeborg Klymiuk; Günter Fasching; Holger Till; Georg Singer Journal: Pediatr Res Date: 2020-11-06 Impact factor: 3.756
Authors: John B O'Connor; Madison M Mottlowitz; Brandie D Wagner; Kathleen L Boyne; Mark J Stevens; Charles E Robertson; Jonathan K Harris; Theresa A Laguna Journal: PLoS One Date: 2021-10-06 Impact factor: 3.752
Authors: John B O'Connor; Madison Mottlowitz; Monica E Kruk; Alan Mickelson; Brandie D Wagner; Jonathan Kirk Harris; Christine H Wendt; Theresa A Laguna Journal: Front Cell Infect Microbiol Date: 2022-03-10 Impact factor: 6.073